Your browser doesn't support javascript.
loading
Cannabis Use Is Associated With Recurrence After Primary Spontaneous Pneumothorax.
Wakefield, Connor J; Seder, Christopher W; Arndt, Andrew T; Geissen, Nicole; Liptay, Michael J; Karush, Justin M.
Afiliação
  • Wakefield CJ; Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, United States.
  • Seder CW; Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, United States.
  • Arndt AT; Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, United States.
  • Geissen N; Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, United States.
  • Liptay MJ; Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, United States.
  • Karush JM; Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, United States.
Front Surg ; 8: 668588, 2021.
Article em En | MEDLINE | ID: mdl-34113644
ABSTRACT

Purpose:

Primary spontaneous pneumothorax (PSP) is a frequently encountered entity that carries a high rate of recurrence. The current study aims to investigate if cannabis use at time of initial PSP is associated with disease recurrence.

Methods:

Patients presenting with PSP between 2010 and 2018 at a single institution were identified. Exclusion criteria included secondary pneumothorax, severe chronic lung disease, lung cancer, and lost to follow-up. Patients were compared relative to their cannabis usage with Fisher's exact test, Wilcoxon rank-sum test, and logistic regression.

Results:

Overall, 67 patients (53 male) met inclusion criteria with a median body mass index (BMI) of 21.5 kg/m2 (IQR 19.1-25.2) and age of 34 years (IQR 22-53). Initial treatment consisted of chest tube in 42 patients (63%), video-assisted thoracoscopic surgery wedge resection in 19 patients (28%), and observation in 6 patients (9%). Cannabis users (n = 28; 42%) had a higher rate of tobacco use (79 vs. 38%; p = 0.005), lower BMI [21.0 kg/m2 (IQR 18.3-23.1) vs. 22.2 kg/m2 (IQR 19.9-28.6), p = 0.037], and were more likely to require intervention at first presentation compared with non-marijuana users. Cannabis use was associated with PSP recurrence when adjusting for tobacco use, BMI, and height (OR 1.85, 95% CI 1.38-18.3, p = 0.014).

Conclusion:

There is a high rate of cannabis usage in patients presenting with PSP. Cannabis usage is associated with PSP recurrence and eventual need for operative intervention.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article